Preprint
AI Safety & Alignment

ProTox-II: a webserver for the prediction of toxicity of chemicals

Priyanka Banerjee(Charité – Universitätsmedizin Berlin), Andreas Philipp Eckert(Charité – Universitätsmedizin Berlin), Anna K. Schrey(Charité – Universitätsmedizin Berlin), Robert Preißner(Freie Universität Berlin)
April 26, 2018Nucleic Acids Research3,218 citations

3.2k

Citations

0

Influential Citations

Nucleic Acids Research

Venue

2018

Year

Abstract

Advancement in the field of computational research has made it possible for the in silico methods to offer significant benefits to both regulatory needs and requirements for risk assessments, and pharmaceutical industry to assess the safety profile of a chemical. Here, we present ProTox-II that incorporates molecular similarity, pharmacophores, fragment propensities and machine-learning models for the prediction of various toxicity endpoints; such as acute toxicity, hepatotoxicity, cytotoxicity, carcinogenicity, mutagenicity, immunotoxicity, adverse outcomes pathways (Tox21) and toxicity targets. The predictive models are built on data from both in vitro assays (e.g. Tox21 assays, Ames bacterial mutation assays, hepG2 cytotoxicity assays, Immunotoxicity assays) and in vivo cases (e.g. carcinogenicity, hepatotoxicity). The models have been validated on independent external sets and have shown strong performance. ProTox-II provides a freely available webserver for in silico toxicity prediction for toxicologists, regulatory agencies, computational and medicinal chemists, and all users without login at http://tox.charite.de/protox_II. The webserver takes a two-dimensional chemical structure as an input and reports the possible toxicity profile of the chemical for 33 models with confidence scores, and an overall toxicity radar chart along with three most similar compounds with known acute toxicity.

Analysis

Why This Paper Matters

ProTox-II addresses a critical need in computational toxicology: the ability to rapidly and freely predict the toxicity of chemicals without relying solely on animal testing or expensive in vitro assays. By integrating multiple computational approaches—molecular similarity, pharmacophores, fragment propensities, and machine learning—the webserver offers a comprehensive toxicity profile for 33 endpoints, covering acute toxicity, organ-specific toxicity, and adverse outcome pathways. This is particularly important for regulatory agencies and the pharmaceutical industry, where early identification of toxic liabilities can save time and resources.

The paper's significance is underscored by its widespread adoption, with over 3,200 citations, indicating its impact on both academic research and industrial practice. ProTox-II democratizes access to toxicity prediction by providing a user-friendly, login-free webserver, enabling toxicologists, chemists, and regulators to perform in silico assessments. This aligns with the broader trend toward computational methods that reduce reliance on animal testing and accelerate the drug discovery process.

Technical Contributions

  • Multi-endpoint prediction: ProTox-II predicts 33 toxicity endpoints, including acute toxicity, hepatotoxicity, cytotoxicity, carcinogenicity, mutagenicity, immunotoxicity, Tox21 pathways, and toxicity targets.
  • Hybrid modeling approach: The system combines molecular similarity, pharmacophore analysis, fragment propensities, and machine-learning models, leveraging both in vitro and in vivo data.
  • User-friendly webserver: The tool accepts 2D chemical structures and returns toxicity predictions with confidence scores, a radar chart for overall toxicity, and the three most similar compounds with known acute toxicity.
  • Free and open access: No login is required, making it accessible to a broad audience.

Results

The abstract states that the models were validated on independent external sets and showed strong performance. However, specific metrics such as accuracy, sensitivity, or AUC are not provided in the abstract. The paper likely reports detailed performance metrics in the full text, but based on the abstract, the key result is the successful development and validation of the webserver. The high citation count suggests that the tool has been widely adopted and validated by the community.

Significance

ProTox-II represents a significant advancement in computational toxicology by providing a freely accessible, multi-endpoint toxicity prediction tool. Its impact extends beyond academia to regulatory agencies and the pharmaceutical industry, where it supports risk assessment and safety profiling. The integration of machine learning with traditional cheminformatics methods demonstrates the value of hybrid approaches in predictive toxicology. As the field moves toward more ethical and efficient testing strategies, tools like ProTox-II are likely to play an increasingly important role in reducing animal testing and accelerating the development of safer chemicals and drugs.